LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 207 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $1,332,000 | +10.9% | 8,622 | 0.0% | 0.14% | +2.1% |
Q3 2021 | $1,201,000 | +6.2% | 8,622 | 0.0% | 0.14% | +7.7% |
Q2 2021 | $1,131,000 | -13.9% | 8,622 | 0.0% | 0.13% | -7.1% |
Q1 2021 | $1,314,000 | +53.3% | 8,622 | 0.0% | 0.14% | +62.8% |
Q4 2020 | $857,000 | +100.2% | 8,622 | +91.9% | 0.09% | +56.4% |
Q3 2020 | $428,000 | -32.7% | 4,494 | -21.0% | 0.06% | -35.3% |
Q2 2020 | $636,000 | +150.4% | 5,687 | +181.5% | 0.08% | +347.4% |
Q1 2019 | $254,000 | -62.9% | 2,020 | -59.9% | 0.02% | -65.5% |
Q4 2018 | $684,000 | -59.1% | 5,040 | -17.3% | 0.06% | +48.6% |
Q3 2018 | $1,673,000 | +296.4% | 6,096 | +199.0% | 0.04% | +362.5% |
Q2 2018 | $422,000 | -73.9% | 2,039 | -93.1% | 0.01% | -55.6% |
Q3 2014 | $1,617,000 | +75.4% | 29,600 | +100.0% | 0.02% | -14.3% |
Q2 2014 | $922,000 | +191.8% | 14,800 | +214.9% | 0.02% | +200.0% |
Q1 2014 | $316,000 | +62.1% | 4,700 | +27.0% | 0.01% | +40.0% |
Q4 2013 | $195,000 | – | 3,700 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |